Mitigating risks by evaluating new rules and regulations due to COVID-19, specifically regarding the implications associated with remote due diligence practices
Best practice updates of due diligence prior to, during, and after a sale to monetize a product in order to reduce time wasted and maximize efficiency
How virtual tools can affect decision making and data tracking more effective and ensure and compliance within regulatory guardrails
How to facilitate global data sharing in a fair way that leverages the capability of information and makes manufacturing and distribution abilities more efficient
Why organization and understanding of IP practices matters more than trying to reinvent the process
Who should Attend
Pharmaceutical, Biotechnology professionals with responsibilities in:
Business Development
Due Diligence
Mergers and Acquisitions
Strategic Alliance/Alliance Management
BD&L
Licensing
Legal and Regulatory Compliance
General Counsel/Corporate Counsel
Digital Partnerships
Legal / IP
Strategic Alliances/Partnerships
Digital Investments
Intellectual Property and Patent Counsel
Management
Search and Evaluation
Key Accounts/Key Account Management (KAM)
Portfolio Management
Safety
Search and Evaluation
Portfolio / Life Cycle Management
Clinical Operations
External Innovation
Compliance
Regulatory Affairs
Transactions
Scientific Assessment
Past Events
2nd Due Diligence for Life Sciences Summit - 23-24 May 2022, Online Event (95799)
Important
Please, check "Due Diligence for Life Sciences Summit" official website for possible changes, before making any traveling arrangements
